Search Results 2221-2230 of 17742 for rheumatoid arthritis
... factor [G-CSF], granulocyte-macrophage colony-stimulating factor [GM-CSF]) ≤ 2 weeks prior to study registration; NOTE: erythropoietin or darbepoetin ...
... factor receptor (EGFR) mutations. Erlotinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies ...
Fibroblast growth factor 21 is associated with increased serum total antioxidant capacity and oxidized lipoproteins in humans with different stages of chronic ...
Clinical Response to Tumor Necrosis Factor-alpha Inhibitor Therapy in the Management of Cardiac Sarcoidosis. Am J Cardiol. 2023 Oct 15; 205:20-27 Epub 2023 ...
... arthritis, Knee arthritis, Osteochondroma, Pelvis fracture, Chondrosarcoma, Chordoma, Soft tissue sarcoma, Sarcoma, Osteosclerotic myeloma, Liposarcoma ...
Conditions treated · Chronic eosinophilic pneumonia · Connective tissue disease-associated interstitial lung disease (scleroderma lung, rheumatoid lung, mixed ...
... factor on tendon healing and adhesion formation. Traumatic brain injury, including socialization, rehabilitation, resilience and reliability testing of ...
A Phase II study to investigate the potential utility of PD 0332991 in the treatment of early stage ER+ Human epidermal growth factor receptor 2 (HER2)- ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your Annual Fund gift can drive advancements in cancer care.